Weinshilboum, Richard M.
Mayo Clinic Graduate School of Biomedical Sciences,
United States
2025 Rank: 24,888
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 122 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24,888 | 27,961 |
| Total Cites | 1,422 | 1,542 |
| H-index | 15 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 40 | 40 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 108 | 108 |
| Number of Single+First+Last Authored Papers | 374 | 374 |
| Total Cites to Single+First+Last Authored Papers | 601 | 631 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,118 | 1,168 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.32 |
| Self-Citation Percentage |
7.78%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 82 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15,913 | 16,797 |
| Total Cites | 1,495 | 1,721 |
| H-index | 16 | 18 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 38 | 38 |
| Total Cites to Single Authored Papers | 34 | 35 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 111 | 117 |
| Number of Single+First+Last Authored Papers | 359 | 359 |
| Total Cites to Single+First+Last Authored Papers | 710 | 785 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,148 | 1,230 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.40 |
| Self-Citation Percentage |
13.13%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 86 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18,246 | 17,118 |
| Total Cites | 2,031 | 2,358 |
| H-index | 20 | 22 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 38 | 38 |
| Total Cites to Single Authored Papers | 42 | 46 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 165 | 177 |
| Number of Single+First+Last Authored Papers | 355 | 355 |
| Total Cites to Single+First+Last Authored Papers | 979 | 1,091 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,591 | 1,719 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.37 |
| Self-Citation Percentage |
13.87%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 80 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17,481 | 16,601 |
| Total Cites | 1,423 | 1,661 |
| H-index | 16 | 19 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 38 | 38 |
| Total Cites to Single Authored Papers | 41 | 43 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 142 | 151 |
| Number of Single+First+Last Authored Papers | 349 | 349 |
| Total Cites to Single+First+Last Authored Papers | 753 | 842 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,106 | 1,207 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.38 |
| Self-Citation Percentage |
14.33%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.